Cargando…

Prevalence of Multidrug-Resistant Tuberculosis and Associated Factors in Ethiopia: A Systematic Review

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) has continued to be a challenge for tuberculosis (TB) control globally. Ethiopia is one of the countries with high MDR-TB burden. OBJECTIVE: The main purpose of this study was to determine the prevalence of MDR-TB and associated factors in Ethiop...

Descripción completa

Detalles Bibliográficos
Autores principales: Asgedom, Solomon Weldegebreal, Teweldemedhin, Mebrahtu, Gebreyesus, Hailay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903304/
https://www.ncbi.nlm.nih.gov/pubmed/29850257
http://dx.doi.org/10.1155/2018/7104921
Descripción
Sumario:BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) has continued to be a challenge for tuberculosis (TB) control globally. Ethiopia is one of the countries with high MDR-TB burden. OBJECTIVE: The main purpose of this study was to determine the prevalence of MDR-TB and associated factors in Ethiopia. METHODS: A systematic review of the literatures on prevalence of MDR-TB and associated factors was conducted in the country. RESULTS: In our electronic search, 546 citations were depicted. Among the total 546 citations described, a total of 22 articles met eligibility criteria and were included in the review article. According to our review, the prevalence of MDR-TB ranged from 0 to 46.3%. The average mean rate of MDR-TB in Ethiopia was found to be 12.6 ± 15.9%. The overall prevalence of MDR-TB in all TB cases was estimated to be 1.4%. From a total of 3849 patients studied, 527 had MDR-TB. Previous exposure to antituberculosis treatment was the most commonly identified risk factor of MDR-TB in Ethiopia. CONCLUSION: Despite relative decline in incidence of MDR-TB, the distribution and prevalence of MDR-TB continued to be a serious challenge for TB control in Ethiopia. Previous exposure to antituberculosis treatment was also the most common risk factor for MDR-TB. Therefore, strong TB and MDR-TB treatment along with tight introduction of follow-up strategies should be applied for better TB control.